If you need more lookups,
subscriptions start at $34 USD/month.
Barry Berkowitz Location
Framingham, MA, US
Barry Berkowitz Work
2010 -now Co-Founder, Chairman of the Board, @ Bessor Pharma
2006 -now Adjunct Professor @
1998 -now Adjunct Professor of Pharmacology and Experimental Therapeutics @
2005 -2007 President and CEO @
2004 -2005 President and CEO @ Scion Pharmaceuticals
1997 -2004 Founder, Chairman of the Board of Directors, and CEO @ New Chemical Entities, Inc. (acquired by Albany Molecular Research, Inc.)
1992 -1997 Co-Founder, President, and CEO @ Myco/ChemGenics Pharmaceuticals (merged with Millennium Pharmaceuticals)
1992 -1993 Co-Founder and CEO (Strong Pharmaceuticals now Fibrogen) @
1988 -1992 Founder, President, and CEO @ Magainin Sciences Inc. (IPO 1991)
1986 -1988 Vice President, Compound Acquisitions and Development (worldwide) @ Smith Kline & French Labs
1985 -1986 Vice President, Biological Sciences and Biopharmaceutical Research and Development @ Smith Kline & French Labs
1979 -1983 Director of Pharmacology @ Smith Kline & French Labs
1968 -1979 Associate Member (1976-1979); Assistant Member (1971-1976); Post-doctoral Fellow (1968-1970) @ Roche Institute of Molecular Biology
Barry Berkowitz Education
University of California, San Francisco
Doctor of Philosophy - PhD (Pharmacology)
Northeastern University
B.S. (Pharmacy) with High Honor
Roche Institute of Molecular Biology
Post Doctoral Fellow (Immuno-Pharmacology Focus)
Barry Berkowitz Summary
Barry Berkowitz, based in Framingham, MA, US, is currently a Adjunct Professor at Northeastern University, Bouvé College of Health Sciences. Barry Berkowitz brings experience from previous roles at Bessor Pharma, Boston University School of Medicine, Cetek Corporation and Scion Pharmaceuticals. Barry Berkowitz holds a Doctor of Philosophy - PhD in Pharmacology @ University of California, San Francisco. Barry Berkowitz has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Barry Berkowitz?
Find contact details for 700 million professionals.